Spiration® Valve System (SVS)

FDA Premarket Approval P180007 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval of 180 day no fee post-approval study (pas) revisions

DeviceSpiration® Valve System (SVS)
Generic NameValve, Pulmonary
ApplicantGyrus ACMI, Inc.
Date Received2020-10-21
Decision Date2020-12-23
PMAP180007
SupplementS007
Product CodeNJK 
Advisory CommitteeAnesthesiology
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonPostapproval Study Protocol - Ode/oir
Expedited ReviewNo
Combination Product No
Applicant Address Gyrus ACMI, Inc. 6675 185th Avenue Ne redmond, WA 98052

Supplemental Filings

Supplement NumberDateSupplement Type
P180007Original Filing
S007 2020-10-21 Normal 180 Day Track No User Fee
S006
S005 2019-11-18 Normal 180 Day Track
S004
S003 2018-12-26 Normal 180 Day Track No User Fee
S002 2018-12-26 Normal 180 Day Track No User Fee
S001

NIH GUDID Devices

Device IDPMASupp
00896506002323 P180007 000
00896506002316 P180007 000
00896506002309 P180007 000
00896506002293 P180007 000
00896506002286 P180007 000
00896506002279 P180007 000

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.